Her primary areas of investigation include Gerontology, Cognition, Internal medicine, Dementia and Clinical Dementia Rating. The Cognition study combines topics in areas such as Developmental psychology and Cognitive decline. Her biological study spans a wide range of topics, including Neuroscience and Brain mapping.
Her Dementia research is multidisciplinary, incorporating elements of Memory impairment and Population study. The Pittsburgh compound B study which covers Asymptomatic that intersects with Neurocognitive. Beth E. Snitz has included themes like Executive functions, Cognitive disorder and Cognitive test in her Neuropsychology study.
Her primary areas of study are Cognition, Dementia, Internal medicine, Cognitive decline and Disease. Beth E. Snitz usually deals with Cognition and limits it to topics linked to Developmental psychology and Executive functions. As part of the same scientific family, Beth E. Snitz usually focuses on Dementia, concentrating on Alzheimer's disease and intersecting with Asymptomatic.
She interconnects Endocrinology, Oncology and Cardiology in the investigation of issues within Internal medicine. Her Cognitive decline research incorporates elements of Effects of sleep deprivation on cognitive performance, Cohort study and Audiology. Her Pittsburgh compound B study combines topics in areas such as Positron emission tomography and Hyperintensity.
Beth E. Snitz focuses on Cognition, Dementia, Cognitive decline, Disease and Clinical psychology. Her Cognition study frequently links to adjacent areas such as Gerontology. Her research in Dementia is mostly concerned with Clinical Dementia Rating.
Her Cognitive decline study integrates concerns from other disciplines, such as Cohort study, Audiology, Multiple morbidities, Subjective memory and Cognitive Changes. Her Disease study is concerned with Internal medicine in general. Her Pittsburgh compound B study incorporates themes from Neuropsychology and Endophenotype.
Her main research concerns Pittsburgh compound B, Apolipoprotein E, Disease, Internal medicine and Cognitive decline. Her study with Pittsburgh compound B involves better knowledge in Cognition. Beth E. Snitz has researched Cognition in several fields, including Neuroimaging and Audiology.
Her Apolipoprotein E research integrates issues from Endophenotype and Amyloid. Her work in the fields of Disease, such as Late onset, intersects with other areas such as Hippocampal sclerosis. Beth E. Snitz studied Cognitive decline and Cohort study that intersect with Epidemiology, Life satisfaction, Cognitive test and Clinical psychology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical versus mechanical prediction: a meta-analysis.
William M. Grove;David H. Zald;Boyd S. Lebow;Beth E. Snitz.
Psychological Assessment (2000)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein;Robert D. Nebes;Judith A. Saxton;Julie C. Price.
JAMA Neurology (2008)
Cognitive Deficits in Unaffected First-Degree Relatives of Schizophrenia Patients: A Meta-analytic Review of Putative Endophenotypes
Beth E. Snitz;Angus W. MacDonald;Cameron S. Carter;Cameron S. Carter.
Schizophrenia Bulletin (2005)
Ginkgo biloba for prevention of dementia: a randomized controlled trial.
Steven T. DeKosky;Steven T. DeKosky;Jeff D. Williamson;Annette L. Fitzpatrick;Richard A. Kronmal.
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.
Beth E. Snitz;Ellen S. O’Meara;Michelle C. Carlson;Alice M. Arnold.
Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees
William E. Klunk;Julie C. Price;Chester A. Mathis;Nicholas D. Tsopelas.
The Journal of Neuroscience (2007)
Amyloid imaging in mild cognitive impairment subtypes
David A. Wolk;David A. Wolk;Julie C. Price;Judy A. Saxton;Beth E. Snitz.
Annals of Neurology (2009)
Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies
Laura A. Rabin;Laura A. Rabin;Laura A. Rabin;Colette M. Smart;Paul K. Crane;Rebecca E. Amariglio.
Journal of Alzheimer's Disease (2015)
Implementation of subjective cognitive decline criteria in research studies.
José L. Molinuevo;Laura A. Rabin;Laura A. Rabin;Rebecca Amariglio;Rachel Buckley;Rachel Buckley;Rachel Buckley.
Alzheimers & Dementia (2017)
Outcomes of Mild Cognitive Impairment by Definition: A Population Study
Mary Ganguli;Beth E. Snitz;Judith A. Saxton;Chung Chou H. Chang.
JAMA Neurology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: